1 / 1
Pharmaceutical
inVag
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
nie mniej niż 109 CFU bakterii kwasu mlekowego: 25% Lactobacillus fermentum 57A, 25% Lactobacillus plantarum 57B, 50% Lactobacillus gasseri 57C
Strength
nie mniej niż 109 CFU bakterii kwasu mlekowego: 25% Lactobacillus fermentum 57A, 25% Lactobacillus plantarum 57B, 50% Lactobacillus gasseri 57C
Pack Size
-
Form
Kapsułki dopochwowe, twarde
Source
Rejestry E-zdrowia
Related Clinical Articles
Scan this QR code to access this page quickly on your mobile device.